the primary treatment; 3 patients had associated symptoms of hearing impairment or loss, and 1 had trigeminal nerve pain and abducent nerve palsy. The median duration of HFS before GKS was 15.5 months (range 3-36 months). The follow-up period ranged from 40 to 110 months (median 84 months). Patient characteristics in this group are summarized in Table 1 .
Radiosurgical Technique
In all 6 cases the Leksell stereotactic coordinate frame (Elekta AB) was applied after the patient had received a local anesthetic agent supplemented with a mild sedative. Stereotactic Gd-enhanced MR imaging, in which 1-mm slice intervals were obtained with volume acquisition, was performed during radiosurgery to determine target coordinates and for dose planning. A 201-source cobalt Gamma Knife unit was used for radiosurgery. The radiation volume was determined and shaped to the tumor margin in all 6 patients by using an average of 14 isocenters (range 8-23 isocenters). In the 4 cases of meningioma, the mean radiosurgical treatment volume was 5.3 cm 3 (range 1.2-9.6 cm 3 ), and the mean radiosurgical tumor margin dose was 14.1 Gy (range 12-18 Gy); in the 2 cases of VS, the radiation volume was 2.5 cm 3 in 1 patient and 11.8 cm 3 in the other, and the margin doses were 11.5 and 12 Gy, respectively.
Clinical Assessments
We subdivided clinical outcomes into 4 categories: excellent, good, fair, and poor. Complete spasm relief after GKS without the use of any medication was defined as an excellent outcome. Patients whose relief from spasm intensity or frequency was more than 90% were considered to have a good outcome. Patients with partial spasm relief (> 50%-90% pain relief) were considered to have a fair outcome. No spasm relief or less than 50% relief was considered a poor outcome.
Results
The follow-up period ranged from 40 to 110 months (mean 84 months). The outcomes of spasm and other cranial nerve defects are detailed in Table 1 . Overall, 4 (66.6%) of the 6 patients experienced excellent outcomes and 1 patient (16.7%) had a good outcome without medication after GKS. Spasm improvement occurred at a mean follow-up time of 12.6 months (range 3-24 months). One patient (16.7%) had a poor outcome.
Follow-up MR images showed control of tumor growth in all 6 patients (100%) at a mean of 84 months after GKS. In 5 patients (83%) the tumor was smaller than it had been at the time of GKS; all 5 patients eventually experienced spasm improvement ( Figs. 1 and 2) .
One patient experienced relief from trigeminal nerve pain and excellent spasm relief simultaneously without any improvement in her abducent nerve palsy. The improvements were associated with tumor shrinkage. Three patients with hearing impairment before GKS did not experience an improvement in hearing function.
Discussion
Most cases of HFS are believed to be caused by vascular compression, but in rare cases, HFS can be caused by tumors. In our experience thus far, cases of tumor-related HFS constituted 2% of all meningiomas and 1.8% of VSs treated by GKS. In a group of 1642 patients with HFS who underwent microsurgery, Han et al. 6 reported that 7 patients (0.4%) harbored tumors. Nagata et al. 16 reported that tumors constituted 2.6% of their total series of 158 patients. Miyazaki and colleagues 15 noted that only 4 (0.3%) of 1310 patients with HFS harbored CPA tumors. Kobata et al. 12 reported that tumors were found in only 7 (0.7%) of 997 patients with HFS. Recently Han and associates 5 reported a large series of patients who underwent microsurgery for HFS; those authors found 55 tumors (0.8%) in 6910 cases. Lee et al. 13 reported 9 patients (0.4%) with tumors among 2050 patients with HFS. In patient groups treated with surgery for tumors, Chang et al. 3 stated that 2 (3%) of 65 intracranial meningiomas presented with HFS, and Samii and Matthies 20 noted that 4 (0.4%) of 1000 patients with VSs presented with HFS. In groups of patients who underwent radiosurgery, Iwai et al. 8 found that facial spasm occurred in 6% of the patients. There is another subgroup of patients with newly developed HFS after radiosurgery for VSs. Pollock 18 reported that 2 (6.7%) of 30 enlarged VSs and 2% of 337 patients who underwent radiosurgery developed new HFS. * ANP = abducent nerve palsy; E = excellent; FN = facial numbness; FU = follow up; G = good; HA = headache; HI = hearing impairment; HL = hearing loss; Improv = Improvement; men = meningioma; NC = no change; P = poor; Rad = radiation; TP = trigeminal nerve pain; ↓ = 25%-50% volume reduction; ↓↓ = 51%-75% volume reduction; ↓↓↓ = more than 75% volume reduction; -= not applicable.
Régis et al. 19 noted HFS in 3% of their patients with VSs following treatment with GKS.
Mechanism of Spasm Relief After Microsurgery and Radiosurgery
The most common cause of HFS is compression of the nerve root by a vascular loop. Only a few cases of compression include tumors, cysts, or vascular malformations as the causative agent. 3, 5, 6, 9, [11] [12] [13] 15, 16, 20, 21 One hypothesis is that tumors induce local compression of the facial nerve root exit zone. According to a few reports on large tumors distal to the facial nerve, vascular compression is a reasonable explanation for the incidence of HFS. 2 Samii and Matthies 20 demonstrated that small VSs and cranial nerve vascular loop compression coexist intraoperatively. An explanation for the favorable result achieved using microsurgery may be that the tumor debulking achieved with resection rapidly relieves pressure on the facial nerve root. 20 As for radiosurgery, we observed that in all cases of improvement there was decreased tumor size. Two patients experienced cessation of spasms 30 and 48 months after tumor shrinkage. Pollock 18 reported the occurrence of new facial spasm due to tumor enlargement in 6 patients 13-26 months (median 20 months) after radiosurgery. This finding provides evidence that tumor size is directly related to facial spasm. Moreover, we also observed that 2 patients experienced spasm relief before marked shrinkage of the tumor volume, and in 2 other patients the time latency of spasm improvement lasted as long as 1.5 years. Since the initial improvement in spasm occurred earlier than tumor shrinkage in these 2 patients, the mechanisms of spasm relief induced by GKS for HFS may be similar to those for idiopathic trigeminal neuralgia. Radiation-induced blockage of the paroxysmal ephaptic transmission in idiopathic trigeminal neuralgia may serve as an explanation for the relief from HFS after GKS. Fraioli et al. 4 reported preliminary results of treatment of idiopathic HFS using radiosurgery or stereotactic hypofractionated radiotherapy and showed that a low radiation dose (8 Gy) directed to the facial nerve improved HFS. Kida et al. 10 observed improvement in 5 of 7 pa- tients with facial or trigeminal nerve hyperfunction, despite the fact that tumor shrinkage was confirmed in only two patients. Peker and coworkers 17 observed complete disappearance of facial spasm 12 months after a VS was treated by GKS with 13 Gy delivered to the tumor margin, despite the fact that the tumor volume remained the same at the 22-month follow-up. That case indicates that GKS may be an option for tumor-related HFS.
Outcomes of Microsurgery and Radiosurgery
Tumor removal is by far the most effective means of relieving tumor-induced HFS in patients who are able to undergo such a procedure safely. Unfortunately, due to the rarity of tumor-induced HFS, only a handful of case reports have been published (Table 2 ). Of 7 patients in whom a tumor was removed, 6 (86%) experienced total relief of pain, as reported by Han et al. 6 Samii and Matthies 20 demonstrated excellent long-term results and freedom from spasm at a mean follow-up time of 9 years in 4 patients with VSs. Nagata et al. 16 noted excellent postoperative recovery after resection of benign tumors in the posterior fossa in their 4 patients (100%). Iwai et al. 8 reported 2 cases, in which one patient had undergone microsurgery alone and the other patient had microsurgery followed by radiosurgery for residual tumor. Both patients obtained freedom from HFS.
In the literature, there are only 2 published cases of benign tumors associated with HFS that were treated by radiosurgery. Peker et al. 17 described a case of VS with disappearance of spasm. Kida and colleagues 10 reported another case involving an epidermoid cyst; in that study the patient also obtained freedom from HFS.
Morbid conditions related to cranial nerves, such as new facial paresis or numbness, are rarely seen in patients who have undergone radiosurgery for skull base tumors. Similar results were observed in our small patient group harboring VSs or CPA meningiomas. In patients treated by microsurgery, transient or permanent facial paresis is relatively high: 9 (10%) of 86 cases have been noted, and other cranial nerve injuries have also been reported ( Table 2) .
As to the onset of improvement, most patients treated by radiosurgery experienced improvement in association with tumor shrinkage, although there was a lag phase of 3-24 months. In patients treated by microsurgery, most patients experienced immediate improvement.
Conclusions
Gamma Knife surgey can be effective in treating tumor-related HFS and controlling tumor growth, especially in cases of CPA meningiomas and VSs. Although a lag phase for spasm relief exists, minimal side effects are expected.
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